NAYO to Announce the Launch of Fully Automated Biobanking Solutions in Europe at Medica 2024
Comunicato Precedente
Comunicato Successivo
Chandler Luo, Chief Executive Officer of NAYO, said, "This exhibition is a fantastic platform for showcasing NAYO's liquid handlers and powerful innovation technology to a global audience. We hope to engage in meaningful discussions on cooperation with partners and leading medical institutions worldwide. By leveraging the flexible-based-platform, we aim to maximize resource utilization, foster close collaborations with medical professionals globally."
About NAYO
Founded in 2016, NAYO is a flexible-based-platform manufacturer of laboratory automation which headquartered in Shanghai, China, and also an original equipment manufacturer (OEM). Based on our platform, we offer more than 240 configurations. Our products cover five categories: liquid handling platforms, integrated equipment, integrated modules, exclusive application products and consumables & accessories. In the future, NAYO will focus on global innovation in laboratory efficiency and convenience, continuously improving products, solutions, and research to enhance quality, efficiency, and safety in life sciences and clinical diagnostics.
Please follow our LinkedIn (linkedin.com/company/nayo-biotec) and visit our website at www.nayolab.com for more information.
Contact Information:
NAYO Biotechnology (Shanghai) Co., Ltd
Iris Lin
[email protected]
View original content:https://www.prnewswire.co.uk/news-releases/nayo-to-announce-the-launch-of-fully-automated-biobanking-solutions-in-europe-at-medica-2024-302297396.html